A Randomized, Double-Blind, Placebo-Controlled Trial of Omalizumab Combined with Oral Immunotherapy (OIT) in the Treatment of Cow's Milk Allergy (CMA): Safety of Dosing

Category Primary study
JournalJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Year 2014
This article has no abstract
Epistemonikos ID: 6abe4b9bd0dfdd169bb2198a4fb918808b3d5362
First added on: Feb 05, 2025